Patient and program characteristics which influence screening for bone mineral disease in people with Cystic Fibrosis
Measuring how the drug elexacaftor/tezacaftor/ivacaftor affects the muscles of breathing, using dynamic chest radiography
Elexacaftor-tezacaftor-ivacaftor provides continued health improvement in lung transplant candidates with cystic fibrosis
Exploring health care provider attitudes and perspectives related to men’s sexual and reproductive health in cystic fibrosis
Is Body Mass Index Associated with Better Lung Function in Children with Pancreatic-Sufficient Cystic Fibrosis?